原发性中枢神经系统淋巴瘤的生物学亚型分类。
Sorting biologic subtypes of primary CNS lymphoma.
机构信息
National Cancer Institute.
出版信息
Blood. 2021 Mar 18;137(11):1436-1437. doi: 10.1182/blood.2020009968.
Abstract
In this issue of , Gandhi et al studied 91 cases of primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS) (PCNSL) and compared the biologic features of tumors associated with Epstein-Barr virus (EBV) to tumors that are EBV using digital gene expression signatures and customized hybrid-capture targeted sequencing panels.
摘要
在本期 中，Gandhi 等人研究了 91 例原发性中枢神经系统弥漫性大 B 细胞淋巴瘤（PCNSL），并使用数字基因表达谱和定制的杂交捕获靶向测序面板比较了与 EBV 相关的肿瘤和 EBV 阳性肿瘤的生物学特征。
相似文献
1
Sorting biologic subtypes of primary CNS lymphoma.
Blood. 2021 Mar 18;137(11):1436-1437. doi: 10.1182/blood.2020009968.
2
Controversies in primary CNS lymphoma.
Expert Rev Neurother. 2005 Jul;5(4):459-64. doi: 10.1586/14737175.5.4.459.
3
Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Cancer. 1994 Aug 15;74(4):1383-97. doi: 10.1002/1097-0142(19940815)74:4<1383::aid-cncr2820740432>3.0.co;2-1.
4
Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma.
Hematol Oncol Clin North Am. 2005 Aug;19(4):597-609, v. doi: 10.1016/j.hoc.2005.05.003.
5
New perspectives for patients with primary CNS lymphoma.
Radiother Oncol. 2017 Aug;124(2):331-332. doi: 10.1016/j.radonc.2017.04.027. Epub 2017 Jul 4.
6
Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
Oncology (Williston Park). 2018 Jan 15;32(1):17-22.
7
Primary central nervous system lymphoma: essential points in diagnosis and management.
Med Oncol. 2017 Apr;34(4):61. doi: 10.1007/s12032-017-0920-7. Epub 2017 Mar 17.
8
Primary CNS lymphoma: in search of the evidence.
Lancet Haematol. 2015 Jun;2(6):e227-8. doi: 10.1016/S2352-3026(15)00091-5. Epub 2015 Jun 3.
9
Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions.
Oncology (Williston Park). 2018 Feb 15;32(2):e11-e19.
10
Neurocognitive functions in primary CNS lymphoma.
Neuro Oncol. 2021 Aug 2;23(8):1220-1221. doi: 10.1093/neuonc/noab113.
引用本文的文献
1
Clinical Characteristics, Prognostic Risk Factors, and Primary Treatment for Elderly Patients with Primary Central Nervous System Lymphoma: A Seer Database-Based Research.
Blood Lymphat Cancer. 2025 Jul 7;15:85-101. doi: 10.2147/BLCTT.S529249. eCollection 2025.
2
Molecular diagnosis of vitreoretinal lymphoma.
Taiwan J Ophthalmol. 2024 Dec 24;15(2):236-244. doi: 10.4103/tjo.TJO-D-24-00052. eCollection 2025 Apr-Jun.
3
Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas.
Blood Adv. 2025 Apr 8;9(7):1485-1491. doi: 10.1182/bloodadvances.2024014635.
4
Clinical outcomes of newly diagnosed primary central nervous system lymphoma treated with zanubrutinib-based combination therapy.
World J Clin Oncol. 2023 Dec 24;14(12):606-619. doi: 10.5306/wjco.v14.i12.606.
5
Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications.
Nat Rev Neurol. 2023 Mar;19(3):160-171. doi: 10.1038/s41582-023-00775-5. Epub 2023 Feb 9.
6
Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis.
Cells. 2022 Sep 4;11(17):2757. doi: 10.3390/cells11172757.
7
The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.
BMC Cancer. 2022 Feb 20;22(1):190. doi: 10.1186/s12885-022-09275-z.
8
Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk.
Microorganisms. 2021 Oct 21;9(11):2191. doi: 10.3390/microorganisms9112191.
本文引用的文献
1
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
Blood. 2021 Mar 18;137(11):1468-1477. doi: 10.1182/blood.2020008520.
2
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
Cancer Cell. 2020 Apr 13;37(4):551-568.e14. doi: 10.1016/j.ccell.2020.03.015.
3
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.
Blood. 2019 Sep 12;134(11):860-866. doi: 10.1182/blood.2019001694. Epub 2019 Jul 18.
4
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Nat Med. 2018 May;24(5):679-690. doi: 10.1038/s41591-018-0016-8. Epub 2018 Apr 30.
5
How I treat T-cell chronic active Epstein-Barr virus disease.
Blood. 2018 Jun 28;131(26):2899-2905. doi: 10.1182/blood-2018-03-785931. Epub 2018 Apr 30.
6
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
N Engl J Med. 2018 Apr 12;378(15):1396-1407. doi: 10.1056/NEJMoa1801445.
7
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
Nature. 2000 Feb 3;403(6769):503-11. doi: 10.1038/35000501.
Zotero 插件